Article
VIGI-4: Development of a Novel Pharmacovigilance Method Using ChatGPT
2024-04-08
Abstract excerpt
This study proposes an innovative pharmacovigilance approach, VIGI-4, leveraging ChatGPT Teams Pro version. Our method involves aggregating data from all phase 4 studies published in February 2024 to identify adverse reactions. These results are categorized by disease state alphabetically, demonstrating the method's capacity to generate structured and easily navigable outputs. The results section is tailored to ex...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 540964d7-e994-5f96-a43e-cd0f66c8638b
- DOI
- 10.20944/preprints202404.0523.v1
